Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Jul;76(1):219–224. doi: 10.1172/JCI111949

Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.

H G Welgus, E J Campbell, Z Bar-Shavit, R M Senior, S L Teitelbaum
PMCID: PMC423750  PMID: 2991337

Abstract

Human macrophages have been implicated in connective tissue remodeling; however, little is known about their direct effects upon collagen degradation. We now report that human alveolar macrophages in culture produced both a collagenase and a collagenase inhibitor. The collagenase was secreted in latent form and could be activated by exposure to trypsin. Collagenase production could be increased three- to fourfold by incubating the cells with lipopolysaccharide, but synthesis was largely unaffected by exposure to phorbol myristate acetate. By several criteria, macrophage collagenase was the same as the collagenase secreted by human skin fibroblasts: (a) they were antigenically indistinguishable in double immunodiffusion; (b) both degraded type III collagen preferentially to type I, had little activity against type II collagen, and none against types IV and V, and (c) their affinity for susceptible collagens was equivalent, Michaelis constant = 1-2 microM. Collagenase inhibitory activity was also present in the macrophage-conditioned medium, and was accounted for by an antigen that showed immunologic and functional identity with the collagenase inhibitor secreted by human skin fibroblasts. The amount of inhibitor released by unstimulated cells, approximately 100 ng/10(6) cells per 24 h, was substantially augmented by both phorbol and lipopolysaccharide, although considerable variability in response to these agents was observed between macrophage populations derived from different subjects. As negligible quantities of collagenase or collagenase inhibitor were detectable intracellularly, it appeared that both proteins were secreted rapidly after synthesis. Thus, human macrophages have the capacity to modulate collagen degradation directly by production of collagenase and collagenase inhibitor.

Full text

PDF
219

Images in this article

221Image
on p.221
221Image
on p.221
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cawston T. E., Murphy G., Mercer E., Galloway W. A., Hazleman B. L., Reynolds J. J. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J. 1983 May 1;211(2):313–318. doi: 10.1042/bj2110313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooper T. W., Bauer E. A., Eisen A. Z. Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res. 1983 May;3(3):205–215. doi: 10.1016/s0174-173x(83)80004-1. [DOI] [PubMed] [Google Scholar]
  3. Gross J., Nagai Y. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1197–1204. doi: 10.1073/pnas.54.4.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Groves W. E., Davis F. C., Jr, Sells B. H. Spectrophotometric determination of microgram quantities of protein without nucleic acid interference. Anal Biochem. 1968 Feb;22(2):195–210. doi: 10.1016/0003-2697(68)90307-2. [DOI] [PubMed] [Google Scholar]
  5. Harris E. D., Jr, Evanson J. M., DiBona D. R., Krane S. M. Collagenase and rheumatoid arthritis. Arthritis Rheum. 1970 Jan-Feb;13(1):83–94. doi: 10.1002/art.1780130109. [DOI] [PubMed] [Google Scholar]
  6. Harris E. D., Jr, Krane S. M. Collagenases (third of three parts). N Engl J Med. 1974 Sep 26;291(13):652–661. doi: 10.1056/NEJM197409262911305. [DOI] [PubMed] [Google Scholar]
  7. Hasty K. A., Hibbs M. S., Kang A. H., Mainardi C. L. Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase. J Exp Med. 1984 May 1;159(5):1455–1463. doi: 10.1084/jem.159.5.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Horwitz A. L., Hance A. J., Crystal R. G. Granulocyte collagenase: selective digestion of type I relative to type III collagen. Proc Natl Acad Sci U S A. 1977 Mar;74(3):897–901. doi: 10.1073/pnas.74.3.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Johnson-Muller B., Gross J. Regulation of corneal collagenase production: epithelial-stromal cell interactions. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4417–4421. doi: 10.1073/pnas.75.9.4417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. King J., Laemmli U. K. Polypeptides of the tail fibres of bacteriophage T4. J Mol Biol. 1971 Dec 28;62(3):465–477. doi: 10.1016/0022-2836(71)90148-3. [DOI] [PubMed] [Google Scholar]
  11. Laskey R. A., Mills A. D. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. doi: 10.1111/j.1432-1033.1975.tb02238.x. [DOI] [PubMed] [Google Scholar]
  12. Macartney H. W., Tschesche H. Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem. 1983 Jan 17;130(1):71–78. doi: 10.1111/j.1432-1033.1983.tb07118.x. [DOI] [PubMed] [Google Scholar]
  13. Macartney H. W., Tschesche H. The collagenase inhibitor from human polymorphonuclear leukocytes. Isolation, purification and characterisation. Eur J Biochem. 1983 Jan 17;130(1):79–83. doi: 10.1111/j.1432-1033.1983.tb07119.x. [DOI] [PubMed] [Google Scholar]
  14. Mainardi C. L., Seyer J. M., Kang A. H. Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages. Biochem Biophys Res Commun. 1980 Dec 16;97(3):1108–1115. doi: 10.1016/0006-291x(80)91490-4. [DOI] [PubMed] [Google Scholar]
  15. Mizel S. B., Dayer J. M., Krane S. M., Mergenhagen S. E. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A. 1981 Apr;78(4):2474–2477. doi: 10.1073/pnas.78.4.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nagai Y., Lapiere C. M., Gross J. Tadpole collagenase. Preparation and purification. Biochemistry. 1966 Oct;5(10):3123–3130. doi: 10.1021/bi00874a007. [DOI] [PubMed] [Google Scholar]
  17. Nagase H., Jackson R. C., Brinckerhoff C. E., Vater C. A., Harris E. D., Jr A precursor form of latent collagenase produced in a cell-free system with mRNA from rabbit synovial cells. J Biol Chem. 1981 Dec 10;256(23):11951–11954. [PubMed] [Google Scholar]
  18. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  19. Rich E. A., Seyer J. M., Kang A. H., Mainardi C. L. Identification of a type V collagen-degrading enzyme from human sputum. Am Rev Respir Dis. 1983 Jul;128(1):166–169. doi: 10.1164/arrd.1983.128.1.166. [DOI] [PubMed] [Google Scholar]
  20. Stricklin G. P., Bauer E. A., Jeffrey J. J., Eisen A. Z. Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry. 1977 Apr 19;16(8):1607–1615. doi: 10.1021/bi00627a013. [DOI] [PubMed] [Google Scholar]
  21. Stricklin G. P., Eisen A. Z., Bauer E. A., Jeffrey J. J. Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry. 1978 Jun 13;17(12):2331–2337. doi: 10.1021/bi00605a012. [DOI] [PubMed] [Google Scholar]
  22. Stricklin G. P., Jeffrey J. J., Roswit W. T., Eisen A. Z. Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry. 1983 Jan 4;22(1):61–68. doi: 10.1021/bi00270a009. [DOI] [PubMed] [Google Scholar]
  23. Stricklin G. P., Welgus H. G. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem. 1983 Oct 25;258(20):12252–12258. [PubMed] [Google Scholar]
  24. Valle K. J., Bauer E. A. Biosynthesis of collagenase by human skin fibroblasts in monolayer culture. J Biol Chem. 1979 Oct 25;254(20):10115–10122. [PubMed] [Google Scholar]
  25. Villiger B., Kelley D. G., Engleman W., Kuhn C., 3rd, McDonald J. A. Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding. J Cell Biol. 1981 Sep;90(3):711–720. doi: 10.1083/jcb.90.3.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wahl L. M., Wahl S. M., Mergenhagen S. E., Martin G. R. Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3598–3601. doi: 10.1073/pnas.71.9.3598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Welgus H. G., Burgeson R. E., Wootton J. A., Minor R. R., Fliszar C., Jeffrey J. J. Degradation of monomeric and fibrillar type III collagens by human skin collagenase. Kinetic constants using different animal substrates. J Biol Chem. 1985 Jan 25;260(2):1052–1059. [PubMed] [Google Scholar]
  28. Welgus H. G., Jeffrey J. J., Eisen A. Z. The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem. 1981 Sep 25;256(18):9511–9515. [PubMed] [Google Scholar]
  29. Welgus H. G., Jeffrey J. J., Stricklin G. P., Roswit W. T., Eisen A. Z. Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem. 1980 Jul 25;255(14):6806–6813. [PubMed] [Google Scholar]
  30. Welgus H. G., Stricklin G. P. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem. 1983 Oct 25;258(20):12259–12264. [PubMed] [Google Scholar]
  31. Werb Z., Gordon S. Secretion of a specific collagenase by stimulated macrophages. J Exp Med. 1975 Aug 1;142(2):346–360. doi: 10.1084/jem.142.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. White R., Janoff A., Godfrey H. P. Secretion of Alpha-2-macroglobulin by human alveolar macrophages. Lung. 1980;158(1):9–14. doi: 10.1007/BF02713697. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES